The Yangtze River Pharmaceutical Group, or YRPG, based in the Gaogang district – also known as the Taizhou Medical High-tech Zone, located in Taizhou city, in East China's Jiangsu province – recently emerged as one of the top companies in the region.
That's according to the 2023 Jiangsu Top 200 Private Enterprises rankings, released by the Jiangsu Federation of Industry and Commerce.
YRPG secured a leading position in such categories as the top 200 private enterprises, the top 100 private manufacturing companies and the leading enterprises in social responsibility.
An employee checks data at Yangtze River Pharmaceutical Group. [Photo/WeChat ID: weigg6666]
YRPG's recognition extends beyond Jiangsu, with the group placed 124th in the list of 2023 China's top 500 private firms by the All-China Federation of Industry and Commerce.
Established in 1971, YRPG was recognized as one of the first innovative enterprises designated by the Ministry of Science and Technology.
It's understood that the company emphasizes quality and has implemented a comprehensive quality control system across its operations.
As a result, YRPG has received prestigious accolades, including the European Quality Award and the Global Excellence Award.
YRPG's commitment to quality, innovation and the healthcare industry is said to have contributed to its success and growth. The company aims to become the leading brand in China's healthcare industry and is striving to become a world-class enterprise.